ABSTRACT NUMBER: ESOC2026A1628 UNDERSTANDING RESIDUAL RISK REDUCTION FROM THE PATIENTS' PERSPECTIVE: A MIXED-METHODS SURVEY OF PATIENTS PRESCRIBED ICOSAPENT ETHYL FOR SECONDARY PREVENTION IN RURAL ENGLISH PRIMARY CARE

Carl Deaney · 2026

Read ABSTRACT NUMBER: ESOC2026A1628 UNDERSTANDING RESIDUAL RISK REDUCTION FROM THE PATIENTS' PERSPECTIVE: A MIXED-METHODS SURVEY OF PATIENTS PRESCRIBED ICOSAPENT ETHYL FOR SECONDARY PREVENTION IN RURAL ENGLISH PRIMARY CARE by Carl Deaney (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13145620.txt.

Description

Carl Deaney surveys stroke patients on a risk-lowering drug in this 2026 conference abstract. After a stroke or mini-stroke, patients still face high risk from artery disease even on standard drugs. Guidelines urge fuller risk control in primary care, past the usual cholesterol target.

The drug at stake is icosapent ethyl, given for raised blood fats in rural English practices. Deaney asked patients how well they grasp the drug's role, how confident they feel, and what support they need. The mixed-methods survey centers the patient's view. It aims to shape care that people can actually follow in country practices.

Catalog record

CREATORCarl Deaney
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13145620

Browse the full library · About the Tower of Babel